Royal Philips has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its IntelliVue MX750 and IntelliVue MX850 acute patient monitors.

Last year, the company secured an emergency use authorisation from FDA for both patient monitors, which will facilitate scalability and alarm management. They will also help provide better cybersecurity and enhanced infection prevention within the hospital.

Both patient monitors are an integrated part of Philip’s future-focused acute patient management solution.

The monitors help hospitals to standardise at a system level and customise the solution in a specific care setting, including virtual or decentralised, to enhance patient care.

Designed to offer full modularity, the monitors are interoperable with other devices and applications such as Philips Patient Information Center iX and IntelliVue XDS software for remote display of critical patient data or at the point of care.

Philips hospital patient monitoring general manager Sandra Lesenfants said: “Continuous patient monitoring plays a vital role in overall patient safety while providing clinicians and caregivers with the holistic view they need to best support their patients and manage their workload.

“Philips Patient Monitors IntelliVue MX750 and MX850 are our most advanced patient monitors and a key part of our modular portfolio of hardware, software, services and consumables that can be tailored to provide integrated monitoring solutions that meet the individual needs of each healthcare provider.”

To simplify clinical workflow with advanced clinical decision support, data also flows between the MX750 and MX850 patient monitors and Philips Acute Care Telehealth command centre.

Through continuous end-to-end encryption, the integrated system securely feeds patient data to a hospital’s electronic medical records, stated the company.

To minimise hospital acquired infections, the patient monitors are provided with a rugged design that can withstand strong hospital-grade disinfectants.